Abstract
We studied 34 MS patients who were treated experimentally by thymectomy with or without 1 year of azathioprine therapy. After 3 years, there was no evidence of benefit. Relapsing-remitting patients had done as well or better clinically than controls, and the chronic progressive group did less well statistically than controls.
Original language | English |
---|---|
Pages (from-to) | 1049-1051 |
Number of pages | 3 |
Journal | Neurology |
Volume | 35 |
Issue number | 7 |
DOIs | |
State | Published - Jul 1985 |